sorafenib has been researched along with forsythiaside in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (forsythiaside) | Trials (forsythiaside) | Recent Studies (post-2010) (forsythiaside) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 119 | 1 | 87 |
| Protein | Taxonomy | sorafenib (IC50) | forsythiaside (IC50) |
|---|---|---|---|
| Protein kinase C alpha type | Homo sapiens (human) | 1.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, JC; Hung, HY; Hwang, TL; Kuo, DH; Kuo, PC; Lee, EJ; Nian, CW; Tai, SH; Wu, TS | 1 |
1 other study(ies) available for sorafenib and forsythiaside
| Article | Year |
|---|---|
Chemical Constituents and Anti-inflammatory Principles from the Fruits of Forsythia suspensa.
Topics: Anti-Inflammatory Agents; Diterpenes; Forsythia; Fruit; Humans; Lignans; Molecular Structure; Neutrophils; Pancreatic Elastase; Superoxides; Taiwan | 2017 |